http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2384651-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efd09c296645384c4e1c770411f7aa01 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 |
| filingDate | 2007-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c222fd4bf39b23d07630c5a588661c46 |
| publicationDate | 2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2384651-T3 |
| titleOfInvention | Methods to identify patients with increased risk of an adverse cardiovascular event |
| abstract | Method to identify a patient who has an increased risk of experiencing an adverse cardiovascular event, in which the patient is undergoing aspirin antiplatelet therapy, said method comprising: (a) evaluating a sample containing platelets of the patient to determine platelet hyperactivity in that the patient is aspirin sensitive, which is defined as a patient for whom aspirin therapy is considered effective, as determined by an optical aggregation method that uses platelet aggregometry induced by arachidonic acid and induced by ADP and (b) relate platelet hyperactivity in the sample with the patient's risk of experiencing an adverse cardiovascular event. |
| priorityDate | 2006-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.